These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 21752717)

  • 1. Role of chemotherapy and biomolecular therapy in the treatment of uterine sarcomas.
    Hensley ML
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):773-82. PubMed ID: 21752717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Chemotherapy and hormone therapy for uterine sarcomas].
    Yamashita H; Arai H; Aoki D
    Gan To Kagaku Ryoho; 2012 May; 39(5):722-5. PubMed ID: 22584323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma.
    Kushner DM; Webster KD; Belinson JL; Rybicki LA; Kennedy AW; Markman M
    Gynecol Oncol; 2000 Aug; 78(2):221-7. PubMed ID: 10926807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The management of patients with uterine sarcoma: a debated clinical challenge.
    Gadducci A; Cosio S; Romanini A; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Feb; 65(2):129-42. PubMed ID: 17706430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant ifosfamide and cisplatin in patients with completely resected stage I or II carcinosarcomas (mixed mesodermal tumors) of the uterus: a Gynecologic Oncology Group study.
    Sutton G; Kauderer J; Carson LF; Lentz SS; Whitney CW; Gallion H;
    Gynecol Oncol; 2005 Mar; 96(3):630-4. PubMed ID: 15721404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative diagnosis and treatment results in 106 patients with uterine sarcoma in Hokkaido, Japan.
    Sagae S; Yamashita K; Ishioka S; Nishioka Y; Terasawa K; Mori M; Yamashiro K; Kanemoto T; Kudo R
    Oncology; 2004; 67(1):33-9. PubMed ID: 15459493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in early stage uterine sarcomas: an open question.
    Gadducci A; Romanini A
    Eur J Gynaecol Oncol; 2001; 22(5):352-7. PubMed ID: 11766739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy for Uterine Carcinosarcoma with Carboplatin, Ifosfamide and Mesna.
    Dandamudi RK; Aslam S; Walji N; El-Modir A; Fernando I
    Anticancer Res; 2015 Sep; 35(9):4841-7. PubMed ID: 26254376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal management of uterine leiomyosarcoma.
    O'Cearbhaill R; Hensley ML
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):153-69. PubMed ID: 20131992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin-based chemotherapy regimen (DECAV) for uterine sarcomas.
    Pautier P; Genestie C; Fizazi K; Morice P; Mottet C; Haie-Meder C; Le Cesne A; Lhommé C
    Int J Gynecol Cancer; 2002; 12(6):749-54. PubMed ID: 12445254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of radiotherapy treatment of uterine sarcoma.
    Sampath S; Gaffney DK
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):761-72. PubMed ID: 21783424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine carcinosarcoma associated with pelvic radiotherapy for sacral chordoma: a case report.
    Kahraman K; Ortac F; Kankaya D; Aynaoglu G
    Taiwan J Obstet Gynecol; 2012 Mar; 51(1):89-92. PubMed ID: 22482976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination chemotherapy of uterine sarcomas].
    Bai P; Zhang W; Sun J
    Zhonghua Zhong Liu Za Zhi; 2000 Jan; 22(1):80-2. PubMed ID: 11776610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesna, doxorubicin, ifosfamide and dacarbazine chemotherapy for uterine leiomyosarcoma: a report of two cases.
    Minobe S; Todo Y; Suzuki Y; Aoyagi Y; Umazume T; Okamoto K; Kato H
    J Obstet Gynaecol Res; 2011 Jun; 37(6):645-9. PubMed ID: 21375676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hysteroscopic resection of uterine leiomyosarcoma: a case report and literature review.
    Nappi L; Di Spiezio Sardo A; Indraccolo U; Bettocchi S
    J Minim Invasive Gynecol; 2008; 15(3):380-3. PubMed ID: 18439518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical treatment of uterine sarcoma.
    Nam JH
    Best Pract Res Clin Obstet Gynaecol; 2011 Dec; 25(6):751-60. PubMed ID: 21764388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical outcome and prognostic factors in 100 cases of uterine sarcoma: experience in Helsinki University Central Hospital 1990-2001.
    Koivisto-Korander R; Butzow R; Koivisto AM; Leminen A
    Gynecol Oncol; 2008 Oct; 111(1):74-81. PubMed ID: 18657852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
    Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
    Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study.
    Sutton G; Brunetto VL; Kilgore L; Soper JT; McGehee R; Olt G; Lentz SS; Sorosky J; Hsiu JG
    Gynecol Oncol; 2000 Nov; 79(2):147-53. PubMed ID: 11063636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of sarcomas of the uterus.
    Novetsky AP; Powell MA
    Curr Opin Oncol; 2013 Sep; 25(5):546-52. PubMed ID: 23942299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.